Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-04-20 00:00:00 ET · period of report 2022-04-18 · accession 0000899243-22-015163 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-20 | 2022-04-18 | VRTX | Lee Yuchun | Dir | M - OptEx | $81.54 | +2,000 | 3,875 | +107% | +$163.1K |
| DM | 2022-04-20 | 2022-04-18 | VRTX | Lee Yuchun | Dir | S - Sale+OE | $284.23 | -2,000 | 3,493 | -36% | -$568.5K |
| D | 2022-04-20 | 2022-04-18 | VRTX | Lee Yuchun | Dir | M - OptEx | $0.00 | -2,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-18 | M | A | 2,000 | $81.54 | 3,875 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-18 | S | D | 119 | $286.80 | 1,875 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $286.80 (range $286.68 to $286.82). |
| 3 | Common | Common Stock | 2022-04-18 | S | D | 1,008 | $284.06 | 2,485 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $284.06 (range $283.72 to $284.46). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2022-04-18 | S | D | 491 | $285.16 | 1,994 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $285.16 (range $284.88 to $285.63). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2022-04-18 | S | D | 382 | $282.70 | 3,493 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $282.70 (range $282.40 to $283.15). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-04-18 | M | D | 2,000 | $0.00 | 0 | D | $81.54 · — to 2023-05-31 | 2,000 Common Stock | (F7) Fully vested. |